Dissection of the Lymphokine-activated Killer Phenomenon. Relative Contribution of Peripheral Blood Natural Killer Cells and T Lymphocytes to Cytolysis

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1986 Sep 1

PMID 3489062

Citations 171

Authors

J H Phillips

L L Lanier

Affiliations

Soon will be listed here.

Abstract

In vitro culture of human peripheral blood lymphocytes in IL-2 results in the generation of cytotoxic cells that can lyse fresh and cultured solid tumor cells, as well as hematopoietic tumor cell lines, without deliberate immunization or MHC restriction. This has been referred to as the lymphokine activated killer (LAK) phenomenon. Here, we show that the majority of this activity is mediated by NK cells that express the Leu-19 (NKH-1) antigen, but do not express CD3. The precursor of this effector population also expressed the phenotype CD3-, Leu-19+. Peripheral blood CD3+ T lymphocytes contributed little to the LAK phenomenon, although low levels of non-MHC restricted cytotoxicity against hematopoietic tumor cell targets were mediated by a subset of CD3+ T lymphocytes that coexpressed the Leu-19 antigen. These studies clearly indicated that the LAK phenomenon is not mediated by a unique LAK cell, but is mediated mainly by IL-2-activated peripheral blood NK cells.

Citing Articles

Inhibiting N-glycan processing increases the antibody binding affinity and effector function of human natural killer cells.

Rodriguez Benavente M, Hughes H, Kremer P, Subedi G, Barb A Immunology. 2023; 170(2):202-213.

PMID: 37218360 PMC: 10524233. DOI: 10.1111/imm.13662.

Incubation of Lymphocytes with IL-2 Causes the Appearance of Antitumor T Cells Carrying FC, CD25, and LFA-1 on the Surface.

Ivanova O, Sharapova T, Romanova E, Yashin D, Sashchenko L Dokl Biochem Biophys. 2023; 508(1):12-16.

PMID: 36653582 PMC: 10042969. DOI: 10.1134/S160767292270003X.

Advanced T and Natural Killer Cell Therapy for Glioblastoma.

Yoon W, Chung D J Korean Neurosurg Soc. 2023; 66(4):356-381.

PMID: 36588388 PMC: 10323271. DOI: 10.3340/jkns.2022.0267.

Next Generation Natural Killer Cells for Cancer Immunotherapy.

Rossi F, Fredericks N, Snowden A, Allegrezza M, Moreno-Nieves U Front Immunol. 2022; 13:886429.

PMID: 35720306 PMC: 9202478. DOI: 10.3389/fimmu.2022.886429.

Efficacy and Safety of Cellular Immunotherapy by Local Infusion for Liver Tumor: A Systematic Review and Meta-Analysis.

Chen S, Chen H, Zhang Y, Li W Front Oncol. 2022; 12:772509.

PMID: 35296019 PMC: 8918675. DOI: 10.3389/fonc.2022.772509.

References

Reinherz E, Hussey R, Schlossman S . A monoclonal antibody blocking human T cell function. Eur J Immunol. 1980; 10(10):758-62. DOI: 10.1002/eji.1830101006. View

Lanier L, Le A, Civin C, Loken M, Phillips J . The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986; 136(12):4480-6. View

Grimm E, Ramsey K, Mazumder A, Wilson D, Djeu J, Rosenberg S . Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med. 1983; 157(3):884-97. PMC: 2186968. DOI: 10.1084/jem.157.3.884. View

Lanier L, Le A, Phillips J, Warner N, Babcock G . Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol. 1983; 131(4):1789-96. View

Grimm E, Robb R, Roth J, Neckers L, Lachman L, Wilson D . Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J Exp Med. 1983; 158(4):1356-61. PMC: 2187385. DOI: 10.1084/jem.158.4.1356. View

Toribio M, de Landazuri M, Lopez-Botet M . Induction of natural killer-like cytotoxicity in cultured human thymocytes. Eur J Immunol. 1983; 13(12):964-9. DOI: 10.1002/eji.1830131203. View

Trinchieri G, Clark S, Seehra J, London L, Perussia B . Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med. 1984; 160(4):1147-69. PMC: 2187474. DOI: 10.1084/jem.160.4.1147. View

Phillips J, Warner N, Lanier L . Correlation of biophysical properties and cell surface antigenic profile of Percoll gradient-separated human natural killer cells. Nat Immun Cell Growth Regul. 1983; 3(2):73-86. View

Lanier L, Benike C, Phillips J, Engleman E . Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J Immunol. 1985; 134(2):794-801. View

10.

Itoh K, Tilden A, Kumagai K, Balch C . Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells. J Immunol. 1985; 134(2):802-7. View

11.

Spits H, Yssel H, Leeuwenberg J, De Vries J . Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3. Eur J Immunol. 1985; 15(1):88-91. DOI: 10.1002/eji.1830150117. View

12.

Hercend T, Griffin J, Bensussan A, Schmidt R, Edson M, Brennan A . Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest. 1985; 75(3):932-43. PMC: 423627. DOI: 10.1172/JCI111794. View

13.

Phillips J, Lanier L . A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562. J Exp Med. 1985; 161(6):1464-82. PMC: 2187621. DOI: 10.1084/jem.161.6.1464. View

14.

Rosenberg S, Lotze M, Muul L, Leitman S, Chang A, Ettinghausen S . Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med. 1985; 313(23):1485-92. DOI: 10.1056/NEJM198512053132327. View

15.

Lanier L, Cwirla S, Federspiel N, Phillips J . Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes. J Exp Med. 1986; 163(1):209-14. PMC: 2188004. DOI: 10.1084/jem.163.1.209. View

16.

Phillips J, Lanier L . Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J Immunol. 1986; 136(5):1579-85. View

17.

Grimm E, Mazumder A, Zhang H, Rosenberg S . Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med. 1982; 155(6):1823-41. PMC: 2186695. DOI: 10.1084/jem.155.6.1823. View